ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM (CombiPatch (estradiol/norethindrone acetate transdermal system)) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the generic name?

ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM

What is the Trade Name for ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM?

CombiPatch (estradiol/norethindrone acetate transdermal system)

What are the Indications for ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM?

  • INDICATIONS AND USAGE CombiPatch is indicated in a woman with a uterus for: Treatment of moderate to severe vasomotor symptoms due to menopause. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. Treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure.

 

View Our Nursing Pharmacology Course


 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.